コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 with cancer types (first cancer, recurrence, second primary cancer).
2 cancer, of whom 1,088 were diagnosed with a second primary cancer.
3 -up (mean: 4.7 years), 279 women developed a second primary cancer.
4 d cancer recurrence, and 57 (2%) developed a second primary cancer.
5 a strong suggestion of an increased risk of second primary cancers.
6 id conditions such as obesity, diabetes, and second primary cancers.
7 respectively) and recipients who developed a second primary cancer after transplantation (aHRs, 1.01;
8 of patients with cancer recurrence and/or a second primary cancer after transplantation are unknown.
9 r Registry were used to evaluate the risk of second primary cancers among a retrospective population-
10 y in 75 trials yielded rate ratios (RRs) for second primary cancers and cause-specific mortality and
11 eriods of follow-up, the AER for deaths from second primary cancers and circulatory causes increased
12 f the excess number of deaths observed while second primary cancers and circulatory deaths together a
13 s of childhood cancer, excess mortality from second primary cancers and circulatory diseases continue
15 atients with multiple gene abnormalities had second primary cancers, and an additional patient had mu
17 tients died of recurrent cancer, two died of second primary cancers, and four died of other causes.
18 revious history of malignancy, recurrent and second primary cancers are infrequent after renal transp
20 surveillance and screening for recurrence or second primary cancers, assessment and management of lon
21 for breast cancer recurrence, screening for second primary cancers, assessment and management of phy
23 lated from 2 months until the diagnosis of a second primary cancer, death, loss to follow-up, or Dece
24 set of patients alive, recurrence-free, and second primary cancer-free (disease-free survival [OS|DF
25 S-mutated tumors were more likely to develop second primary cancers (HR = 2.76, 95% CI, 1.34 to 5.70;
28 kewise, retinoids prevent the development of second primary cancers in head/neck and lung cancer pati
32 By March 15, 2005, 394 events (recurrent, second primary cancer, or death before recurrence) had b
33 tic recurrence at other sites, occurrence of second primary cancer, or death resulting from noncancer
35 mary cancer should be carefully screened for second primary cancers, particularly for cancers that ar
37 t investigating the distribution and risk of second primary cancers (SPCs) in multiple myeloma (MM) s
38 ed in the rates of treatment-related deaths, second primary cancers, thromboembolic events, and perip
40 ent-free survival (with events that included second primary cancers) was significantly improved with
41 en radiation exposure and risks of first and second primary cancers were quantified using Poisson reg
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。